CHEK2 and cancer: Given that CHEK2 is primarily associated with malignancies typically presenting in adulthood,8, 9, 10 prior findings emphasize the importance of long‐term post‐HSCT surveillance to assess the potential impact of CHEK2 variants on late‐onset complications and secondary cancer development.